
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-07-01-2015
- Volume 11
- Issue 7
GS1 US Appoints Greg Bylo Vice-President of Healthcare
Bylo has been selected to lead the GS1 Healthcare US Industry Initiative, focused on driving adoption and usage of GS1 Standards in healthcare.
GS1 US has appointed Greg Bylo vice-president, healthcare to lead GS1 Healthcare US, an industry-wide initiative combining pharmaceutical, medical device, provider, and patient care professionals that are collaborating to drive the adoption of GS1 Standards for improved patient safety and supply chain performance in the healthcare industry. The initiative is also focused on GS1 Standards implementation to support the FDA Drug Supply Chain Security Act and Unique Device Identification (UDI) Rule requirements.
Prior to joining GS1 US, Bylo was the senior director of global supply chain support services at Integra Life Sciences where he was responsible for supply chain planning of global products. He also spent more than 15 years at Becton Dickinson leading sales and operations planning and supply chain planning teams that were focused on decreasing organizational supply chain costs and increasing customer engagement.
Bylo earned a bachelor of science degree in mechanical engineering and material science from the University of Connecticut. He is a Certified Quality Engineer from the American Society of Quality, a member of the Association for Planning and Inventory Control and a certified Six Sigma Green Belt.
Source:
Articles in this issue
almost 11 years ago
SGS Completes New Labs at Shanghai Facilityalmost 11 years ago
American Airlines Cargo Opens Philadelphia Facilityalmost 11 years ago
Assay Testing Shifts to Outsourced Operationsalmost 11 years ago
New Ways Around Hazardous Reagent Chemistryalmost 11 years ago
Making Manufacturing Modernization Easieralmost 11 years ago
EMVO Names Service Providers for FMD Projectalmost 11 years ago
Novasep Plans ADC Facility in Francealmost 11 years ago
Pharmacy Associations Ask FDA to Delay Track-and-Trace Requirementsabout 11 years ago
FDA Issues Guidance on Allowable Excess Volume for Injectables



